Tell Us How Librela Has Helped Control Your Dog's Osteoarthritis Pain

By submitting your story, you accept our Terms and Conditions and our Terms of Use, you warrant and represent that your dog has been diagnosed with osteoarthritis (OA) pain by a licensed veterinarian and has been prescribed Librela (bedinvetmab injection) for control of OA pain.

IMPORTANT SAFETY INFORMATION: Librela is for use in dogs only. Women who are pregnant, trying to conceive or breastfeeding should take extreme care to avoid self-injection. Hypersensitivity reactions, including anaphylaxis, could potentially occur with self-injection. Librela should not be used in breeding, pregnant, or lactating dogs. Librela should not be administered to dogs with known hypersensitivity to bedinvetmab. Adverse events reported post-approval include ataxia (lack of balance/coordination), anorexia (loss of appetite), lethargy (tiredness), emesis (vomiting), and polydipsia (increased drinking). The most common adverse events reported in a clinical study were urinary tract infections, bacterial skin infections and dermatitis (skin irritation/inflammation). See full Prescribing Information.

See the Client Information Sheet for more information about Librela.